Navigating the New Frontier: The 340B Rebate Pilot Model, Legal Landscape, and Technology Solutions

January 14, 2026 at 12 - 1PM ET

Join 340B industry experts Ted Slafsky, Publisher and CEO of 340B Report, and AJ Rivosecchi, PharmD, Product Director at Bluesight, for a presentation and Q&A session on the recent, unprecedented changes to the 340B program, and the impact those changes are having on your team today - and what they could mean in the future. 

As covered entities begin planning for the transition from upfront 340B discounts to a rebate model for key medications, hospitals and other 340B providers face significant cash flow challenges, operational complexity, and new compliance concerns.

RSVP for actionable guidance to help your organization maintain savings while adapting to these regulatory changes.